Treatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in Italy: findings from a retrospective administrative database analysis

Walid Fakhouri,1 Pedro Lopez-Romero,2 Silvia Antonelli,3 Serena Losi,4 Veronica Rogai,4 Stefano Buda,5 Diego Sangiorgi,5 Valentina Perrone,5 Luca Degli Esposti5 1Eli Lilly & Company, Erl Wood, UK; 2Eli Lilly & Company, Madrid, Spain; 3Eli Lilly Italy S.p.A., Roma, I...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fakhouri W, Lopez-Romero P, Antonelli S, Losi S, Rogai V, Buda S, Sangiorgi D, Perrone V, Degli Esposti L
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/06221df7cf294e5fadc47b4b581f0ab7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:06221df7cf294e5fadc47b4b581f0ab7
record_format dspace
spelling oai:doaj.org-article:06221df7cf294e5fadc47b4b581f0ab72021-12-02T06:29:54ZTreatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in Italy: findings from a retrospective administrative database analysis1179-156Xhttps://doaj.org/article/06221df7cf294e5fadc47b4b581f0ab72018-08-01T00:00:00Zhttps://www.dovepress.com/treatment-patterns-health-care-resource-utilization-and-costs-of-rheum-peer-reviewed-article-OARRRhttps://doaj.org/toc/1179-156XWalid Fakhouri,1 Pedro Lopez-Romero,2 Silvia Antonelli,3 Serena Losi,4 Veronica Rogai,4 Stefano Buda,5 Diego Sangiorgi,5 Valentina Perrone,5 Luca Degli Esposti5 1Eli Lilly & Company, Erl Wood, UK; 2Eli Lilly & Company, Madrid, Spain; 3Eli Lilly Italy S.p.A., Roma, Italy; 4Eli Lilly Italy S.p.A., Sesto Fiorentino, Italy; 5CliCon S.r.l. Health, Economics & Outcomes Research, Ravenna, Italy Objectives: This study aimed to: 1) describe treatment patterns and drug utilization profile (in terms of therapeutic strategy used, switch, persistence and drug consumption variation) among adult patients affected by rheumatoid arthritis (RA), and 2) estimate the health care resource utilization and its associated direct cost for the management of RA patients. Methods: A retrospective cohort analysis, using administrative databases of six Local Health Units in Italy, was performed. All adult patients with a confirmed diagnosis of RA between January 1, 2010 and December 31, 2014 were enrolled. The date of the first RA diagnosis according to the study criteria during the study period represented the index date (ID) for each patient. Patients enrolled were observed from the ID for at least 12 months (follow-up period), and their clinical characteristics were investigated for 12 months prior to the ID.Results: A total of 10,401 patients with a confirmed RA diagnosis were included. Mean age was 63.0 years and 25% were male; 67% of patients were untreated at ID. During the follow-up period, 67.8% of patients treated with biologic agents were persistent with initial therapy, compared to 45.7% for patients on conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), while 11% of patients treated with biologic agents switched during the follow-up period, compared to 17.6% of csDMARDs-treated ones. At the end of the follow-up period, 14.7% of all patients in the analysis had an increase and 12.6% of them had a decrease in their initial drug consumption. The mean cost per RA patient was €3,743.Conclusion: Our study showed that there is still much that needs to be learned about the prescription of csDMARDs and biologics to RA patients in Italy and to identify areas for future research. The knowledge of RA management in a real-life clinical setting could offer an opportunity to improve the management of RA in Italy. Keywords: rheumatoid arthritis, treatment patterns, drug utilization, real-world dataFakhouri WLopez-Romero PAntonelli SLosi SRogai VBuda SSangiorgi DPerrone VDegli Esposti LDove Medical PressarticleRheumatoid ArthritisTreatment PatternsDrug UtilizationReal-World Data.Diseases of the musculoskeletal systemRC925-935ENOpen Access Rheumatology: Research and Reviews, Vol Volume 10, Pp 103-111 (2018)
institution DOAJ
collection DOAJ
language EN
topic Rheumatoid Arthritis
Treatment Patterns
Drug Utilization
Real-World Data.
Diseases of the musculoskeletal system
RC925-935
spellingShingle Rheumatoid Arthritis
Treatment Patterns
Drug Utilization
Real-World Data.
Diseases of the musculoskeletal system
RC925-935
Fakhouri W
Lopez-Romero P
Antonelli S
Losi S
Rogai V
Buda S
Sangiorgi D
Perrone V
Degli Esposti L
Treatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in Italy: findings from a retrospective administrative database analysis
description Walid Fakhouri,1 Pedro Lopez-Romero,2 Silvia Antonelli,3 Serena Losi,4 Veronica Rogai,4 Stefano Buda,5 Diego Sangiorgi,5 Valentina Perrone,5 Luca Degli Esposti5 1Eli Lilly & Company, Erl Wood, UK; 2Eli Lilly & Company, Madrid, Spain; 3Eli Lilly Italy S.p.A., Roma, Italy; 4Eli Lilly Italy S.p.A., Sesto Fiorentino, Italy; 5CliCon S.r.l. Health, Economics & Outcomes Research, Ravenna, Italy Objectives: This study aimed to: 1) describe treatment patterns and drug utilization profile (in terms of therapeutic strategy used, switch, persistence and drug consumption variation) among adult patients affected by rheumatoid arthritis (RA), and 2) estimate the health care resource utilization and its associated direct cost for the management of RA patients. Methods: A retrospective cohort analysis, using administrative databases of six Local Health Units in Italy, was performed. All adult patients with a confirmed diagnosis of RA between January 1, 2010 and December 31, 2014 were enrolled. The date of the first RA diagnosis according to the study criteria during the study period represented the index date (ID) for each patient. Patients enrolled were observed from the ID for at least 12 months (follow-up period), and their clinical characteristics were investigated for 12 months prior to the ID.Results: A total of 10,401 patients with a confirmed RA diagnosis were included. Mean age was 63.0 years and 25% were male; 67% of patients were untreated at ID. During the follow-up period, 67.8% of patients treated with biologic agents were persistent with initial therapy, compared to 45.7% for patients on conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), while 11% of patients treated with biologic agents switched during the follow-up period, compared to 17.6% of csDMARDs-treated ones. At the end of the follow-up period, 14.7% of all patients in the analysis had an increase and 12.6% of them had a decrease in their initial drug consumption. The mean cost per RA patient was €3,743.Conclusion: Our study showed that there is still much that needs to be learned about the prescription of csDMARDs and biologics to RA patients in Italy and to identify areas for future research. The knowledge of RA management in a real-life clinical setting could offer an opportunity to improve the management of RA in Italy. Keywords: rheumatoid arthritis, treatment patterns, drug utilization, real-world data
format article
author Fakhouri W
Lopez-Romero P
Antonelli S
Losi S
Rogai V
Buda S
Sangiorgi D
Perrone V
Degli Esposti L
author_facet Fakhouri W
Lopez-Romero P
Antonelli S
Losi S
Rogai V
Buda S
Sangiorgi D
Perrone V
Degli Esposti L
author_sort Fakhouri W
title Treatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in Italy: findings from a retrospective administrative database analysis
title_short Treatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in Italy: findings from a retrospective administrative database analysis
title_full Treatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in Italy: findings from a retrospective administrative database analysis
title_fullStr Treatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in Italy: findings from a retrospective administrative database analysis
title_full_unstemmed Treatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in Italy: findings from a retrospective administrative database analysis
title_sort treatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in italy: findings from a retrospective administrative database analysis
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/06221df7cf294e5fadc47b4b581f0ab7
work_keys_str_mv AT fakhouriw treatmentpatternshealthcareresourceutilizationandcostsofrheumatoidarthritispatientsinitalyfindingsfromaretrospectiveadministrativedatabaseanalysis
AT lopezromerop treatmentpatternshealthcareresourceutilizationandcostsofrheumatoidarthritispatientsinitalyfindingsfromaretrospectiveadministrativedatabaseanalysis
AT antonellis treatmentpatternshealthcareresourceutilizationandcostsofrheumatoidarthritispatientsinitalyfindingsfromaretrospectiveadministrativedatabaseanalysis
AT losis treatmentpatternshealthcareresourceutilizationandcostsofrheumatoidarthritispatientsinitalyfindingsfromaretrospectiveadministrativedatabaseanalysis
AT rogaiv treatmentpatternshealthcareresourceutilizationandcostsofrheumatoidarthritispatientsinitalyfindingsfromaretrospectiveadministrativedatabaseanalysis
AT budas treatmentpatternshealthcareresourceutilizationandcostsofrheumatoidarthritispatientsinitalyfindingsfromaretrospectiveadministrativedatabaseanalysis
AT sangiorgid treatmentpatternshealthcareresourceutilizationandcostsofrheumatoidarthritispatientsinitalyfindingsfromaretrospectiveadministrativedatabaseanalysis
AT perronev treatmentpatternshealthcareresourceutilizationandcostsofrheumatoidarthritispatientsinitalyfindingsfromaretrospectiveadministrativedatabaseanalysis
AT degliespostil treatmentpatternshealthcareresourceutilizationandcostsofrheumatoidarthritispatientsinitalyfindingsfromaretrospectiveadministrativedatabaseanalysis
_version_ 1718399853260701696